Janssen’s TAR-200 Shows High Complete Response Rate in Bladder Cancer Study
Johnson & Johnson (J&J; NYSE: JNJ) subsidiary Janssen has published data from a Phase IIb...
Novartis’ Kisqali Plus Endocrine Therapy Shows Improved Survival in Early Breast Cancer Study
Switzerland-based pharmaceutical company Novartis (NYSE: NVS) has announced additional results from an ongoing Phase III...
Boehringer Ingelheim Appoints Mohammed Tawil as New CEO for Greater China Region
Germany’s Boehringer Ingelheim (BI) has announced a leadership transition within its Greater China region, which...
Pfizer’s Penbraya Receives FDA Approval for Meningococcal Immunization
Pfizer Inc. (NYSE: PFE) announced last week that it has successfully registered its pentavalent meningococcal...
National VBP Tender Program Invites Drugs Approved Before October 30 for Round 9
The National Allied Procurement Office has released a notification regarding Round 9 of the national...
MSD Cancels Development of Two Pre-Clinical ADCs from Sichuan Kelun-Biotech
China-based Sichuan Kelun Pharmaceutical Co., Ltd (SHE: 002422) and its innovative drug development subsidiary Sichuan...
Health Canada Approves Pfizer and Sumitomo Pharma’s Myfembree for Endometriosis Pain Management
Health Canada has granted regulatory approval to Pfizer (NYSE: PFE) and Sumitomo Pharma (TYO: 4506)...
Shanghai Henlius Receives GMP Certification from ANVISA for Biosimilar Manufacturing
China-based Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) subsidiary Shanghai Henlius Biotech,...
Shanghai Fudan-Zhangjiang’s ADC FZ-AD005 Accepted for NMPA Review in Advanced Solid Tumors
China-based Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd (HKG: 1349; SHA: 688505) has announced that the National...
AcuVu Medical Partners with Hologic for US Distribution of HummingScope Hysteroscopy System
AcuVu Medical, a specialist in electronic endoscopes with operations in California, USA, and Suzhou, China,...
CBC HIP Secures USD 875 Million for Life Science Real Assets Venture CLSRA
CBC Healthcare Infrastructure Platform (CBC HIP), a prominent independent life science real assets investor in...
BeiGene’s Brukinsa Gains NICE Recommendation for CLL Treatment in the UK
China-based biotech BeiGene Ltd (NASDAQ: BGNE; HKG: 6160; SHA: 688235) has announced that the National...
Jacobio Pharma’s Glecirasib Combo Shows Promising Results in ESMO Congress 2023 Presentation
China-based Jacobio Pharma (HKG: 1167) has presented clinical data for its KRAS G12C inhibitor glecirasib...
Hotgen Biotech Partners with Genoval Therapeutics for RNAi Drug Development
China’s Hotgen Biotech Co., Ltd (SHA: 688068) has announced a strategic partnership between its anti-aging...
Hansoh Pharmaceutical and GSK Ink Global Licensing Deal for Innovative ADC HS-20089
China-based Hansoh Pharmaceutical Group Co., Ltd (HKG: 3692) has entered into a licensing agreement with...
InxMed Presents Positive Data for FAK Inhibitor Ifebemtinib at ESMO 2023
China-based firm InxMed (Nanjing) Co., Ltd has updated two clinical studies for its first-in-class small-molecule...
Foundation Medicine Expands Genomic Profiling Partnership with Sequanta Technologies in China
US-based Contract Research Organization (CRO) Foundation Medicine Inc. has announced the expansion of its existing...
Jenscare’s LuX-Valve Plus Completes Compassionate Use Cases in Asia-Pacific
Jenscare Scientific Co., Ltd (HKG: 9877), a leading device maker specializing in structural heart disease...
Fosun Pharmaceutical to Acquire 14% Stake in UnitedHealthcare for USD 34 Million
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196) has announced plans to invest RMB 248.9...
Beijing SL Pharmaceutical Gains NMPA Approval for Phase I Trial of MBT-1608 for Hepatitis C
China’s Beijing SL Pharmaceutical Co., Ltd (SHE: 002038) has announced that it has received approval...